Rubedo has completed its first human clinical trial of RLS-1496 with positive results

Rubedo Life Sciences has just announced positive early results from its first human clinical trial of anti-aging treatment, RLS-1496. The biotech company said the drug worked “even better than should be expected” in the short 4-week trial in Europe.  RLS-1496 is a potential first-in-class drug that is meant to selectively target zombie or “aged” cells […]